natgillin/translations-raw huggingface dataset:
In such a case Member States shall immediately inform the third-country national concerned about the possibility of taking such proceedings.
V tem primeru države članice nemudoma obvestijo zadevnega državljana tretje države o možnosti uvedbe takega postopka.
The third-country national concerned shall be released immediately if the detention is not lawful.
Če je pridržanje nezakonito, se zadevnega državljana tretje države nemudoma izpusti.
In every case, detention shall be reviewed at reasonable intervals of time either on application by the third-country national concerned or ex officio.
V vsakem primeru se na zahtevo zadevnega državljana tretje države ali po uradni dolžnosti pridržanje pregleda v razumnih časovnih presledkih.
In the case of prolonged detention periods, reviews shall be subject to the supervision of a judicial authority.
V primeru podaljšanja pridržanja pregled nadzira sodni organ.
When it appears that a reasonable prospect of removal no longer exists for legal or other considerations or the conditions laid down in paragraph 1 no longer exist, detention ceases to be justified and the person concerned shall be released immediately.
Kadar s pravnega vidika ali iz drugih razlogov ni več upravičeno pričakovati odstranitve ali ker pogoji iz odstavka 1 niso več izpolnjeni, pridržanje ni več upravičeno in zadevna oseba se nemudoma izpusti.
Detention shall be maintained for as long a period as the conditions laid down in paragraph 1 are fulfilled and it is necessary to ensure successful removal.
Pridržanje traja, dokler so izpolnjeni pogoji iz odstavka 1 in kolikor je to potrebno, da se zagotovi uspešna odstranitev.
Each Member State shall set a limited period of detention, which may not exceed six months.
Vsaka država članica določi omejeno obdobje pridržanja, ki ne sme presegati šestih mesecev.
Member States may not extend the period referred to in paragraph 5 except for a limited period not exceeding a further twelve months in accordance with national law in cases where regardless of all their reasonable efforts the removal operation is likely to last longer owing to:
Države članice ne smejo podaljšati obdobja iz odstavka 5, razen za omejeno obdobje, ki v skladu z nacionalno zakonodajo ne sme presegati dvanajst mesecev, kadar obstaja verjetnost, da bo postopek odstranitve kljub vsem ustreznim prizadevanjem trajal dlje zaradi:
a lack of cooperation by the third-country national concerned, or
nezadostnega sodelovanja zadevnega državljana tretje države, ali
delays in obtaining the necessary documentation from third countries.
zamud pri pridobivanju potrebne dokumentacije iz tretjih držav.
Conditions of detention
Pogoji pridržanja
Detention shall take place as a rule in specialised detention facilities.
Pridržanje se praviloma izvaja v posebnih centrih za pridržanje.
Where a Member State cannot provide accommodation in a specialised detention facility and is obliged to resort to prison accommodation, the third-country nationals in detention shall be kept separated from ordinary prisoners.
Če država članica ne more zagotoviti nastanitve v posebnem centru za pridržanje in mora za to uporabiti nastanitev v zaporu, so državljani tretjih držav v pridržanju ločeni od navadnih zapornikov.
Third-country nationals in detention shall be allowed — on request — to establish in due time contact with legal representatives, family members and competent consular authorities.
Državljanom tretjih držav v pridržanju se na zahtevo dovoli, da pravočasno vzpostavijo stik z zakonitimi zastopniki, družinskimi člani in pristojnimi konzularnimi organi.
Particular attention shall be paid to the situation of vulnerable persons.
Posebna pozornost se posveti razmeram ranljivih oseb.
Emergency health care and essential treatment of illness shall be provided.
Zagotovi se nujna zdravstvena oskrba in osnovno zdravljenje.
Relevant and competent national, international and non-governmental organisations and bodies shall have the possibility to visit detention facilities, as referred to in paragraph 1, to the extent that they are being used for detaining third-country nationals in accordance with this Chapter.
Ustrezne in pristojne nacionalne, mednarodne in nevladne organizacije ter organi imajo možnost obiskati centre za pridržanje iz odstavka 1, kolikor so ti uporabljeni za pridržanje državljanov tretjih držav v skladu v tem poglavjem.
Such visits may be subject to authorisation.
Za takšne obiske se lahko zahteva dovoljenje.
Third-country nationals kept in detention shall be systematically provided with information which explains the rules applied in the facility and sets out their rights and obligations.
Pridržanim državljanom tretjih držav se redno zagotavljajo informacije, ki pojasnjujejo pravila v centru in določajo njihove pravice in obveznosti.
Such information shall include information on their entitlement under national law to contact the organisations and bodies referred to in paragraph 4.
Te informacije vključujejo tudi informacije o pravici – v skladu z nacionalno zakonodajo – do stikov z organizacijami in organi iz odstavka 4.
Detention of minors and families
Pridržanje mladoletnikov in družin
Unaccompanied minors and families with minors shall only be detained as a measure of last resort and for the shortest appropriate period of time.
Mladoletniki brez spremstva in družine z mladoletniki se pridržijo le, ko so izrabljena vsa druga sredstva in za najkrajše ustrezno obdobje.
Families detained pending removal shall be provided with separate accommodation guaranteeing adequate privacy.
Družinam, pridržanim pred odstranitvijo, se zagotovi ločena namestitev, kjer je zagotovljena ustrezna zasebnost.
Minors in detention shall have the possibility to engage in leisure activities, including play and recreational activities appropriate to their age, and shall have, depending on the length of their stay, access to education.
Pridržani mladoletniki se lahko v prostem času ukvarjajo z dejavnostmi, vključno z igrami in rekreacijskimi dejavnostmi, primernimi njihovi starosti, ter imajo, odvisno od dolžine prebivanja, dostop do izobraževanja.
Unaccompanied minors shall as far as possible be provided with accommodation in institutions provided with personnel and facilities which take into account the needs of persons of their age.
Mladoletnikom brez spremstva se, kolikor je le mogoče, zagotovi namestitev v ustanovah, ki imajo osebje in zmogljivosti, ki upoštevajo potrebe oseb njihove starosti.
The best interests of the child shall be a primary consideration in the context of the detention of minors pending removal.
Pri pridržanju mladoletnikov pred odstranitvijo je najpomembneje ravnati v korist otroka.
Emergency situations
Nujne razmere
In situations where an exceptionally large number of third-country nationals to be returned places an unforeseen heavy burden on the capacity of the detention facilities of a Member State or on its administrative or judicial staff, such a Member State may, as long as the exceptional situation persists, decide to allow for periods for judicial review longer than those provided for under the third subparagraph of Article 15(2) and to take urgent measures in respect of the conditions of detention derogating from those set out in Articles 16(1) and 17(2).
Če nenavadno veliko število državljanov tretjih držav, ki se morajo vrniti, predstavlja nepredvideno veliko breme za zmogljivosti centrov za pridržanje v državi članici ali za njeno upravno ali sodno osebje, lahko ta država članica v času takšnih izrednih razmer dovoli obdobja za sodni pregled, ki so daljša od obdobij iz tretjega pododstavka člena 15(2), in sprejme nujne ukrepe v zvezi s pogoji pridržanja, ki odstopajo od tistih iz členov 16(1) in 17(2).
When resorting to such exceptional measures, the Member State concerned shall inform the Commission.
Če se zadevna država članica zateče k takšnim izrednim ukrepom, o tem obvesti Komisijo.
It shall also inform the Commission as soon as the reasons for applying these exceptional measures have ceased to exist.
Slednjo obvesti tudi takoj, ko ni več vzrokov za uporabo teh izrednih ukrepov.
Nothing in this Article shall be interpreted as allowing Member States to derogate from their general obligation to take all appropriate measures, whether general or particular, to ensure fulfilment of their obligations under this Directive.
Nič v tem členu se ne sme razumeti kot dovoljenje državam članicam, da odstopajo od svoje splošne obveznosti za sprejetje vseh ustreznih, bodisi splošnih ali posebnih, ukrepov, da zagotovijo izpolnjevanje svojih obveznosti iz te direktive.
The Commission shall report every three years to the European Parliament and the Council on the application of this Directive in the Member States and, if appropriate, propose amendments.
Komisija vsaka tri leta Evropskemu parlamentu in Svetu poroča o uporabi te direktive v državah članicah, če je primerno, predlaga spremembe.
The Commission shall report for the first time by 24 December 2013 and focus on that occasion in particular on the application of Article 11, Article 13(4) and Article 15 in Member States.
Komisija prvič poroča do 24. decembra 2013 in se pri tem osredotoči zlasti na uporabo členov 11, 13(4) in 15 v državah članicah.
In relation to Article 13(4) the Commission shall assess in particular the additional financial and administrative impact in Member States.
V zvezi s členom 13(4) Komisija oceni zlasti dodatne finančne in upravne učinke v državah članicah.
Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 24 December 2010.
Države članice sprejmejo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 24. decembra 2010.
In relation to Article 13(4), Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 24 December 2011.
V zvezi s členom 13(4) države članice sprejmejo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 24. decembra 2011.
They shall forthwith communicate to the Commission the text of those measures.
Besedilo teh določb takoj sporočijo Komisiji.
Relationship with the Schengen Convention
Povezava s schengensko konvencijo
This Directive replaces the provisions of Articles 23 and 24 of the Convention implementing the Schengen Agreement.
Ta direktiva nadomešča določbe členov 23 in 24 Konvencije o izvajanju Schengenskega sporazuma.
Opinion of the European Parliament of 18 June 2008 (not yet published in the Official Journal) and Council Decision of 9 December 2008.
Mnenje Evropskega parlamenta z dne 18. junija 2008 (še ni objavljeno v Uradnem listu) in Sklep Sveta z dne 9. decembra 2008.
Regulation (EC) No 562/2006 of the European Parliament and of the Council of 15 March 2006 establishing a Community Code on the rules governing the movement of persons across borders (Schengen Borders Code) (OJ L 105, 13.4.2006, p. 1).
Uredba (ES) št. 562/2006 Evropskega parlamenta in Sveta z dne 15. marca 2006 o Zakoniku Skupnosti o pravilih, ki urejajo gibanje oseb prek meja (Zakonik o schengenskih mejah) (UL L 105, 13.4.2006, str. 1).
OJ L 261, 6.8.2004, p. 19.
UL L 261, 6.8.2004, str. 19.
Commission Directive 2008/116/EC
Direktiva Komisije 2008/116/ES
amending Council Directive 91/414/EEC to include aclonifen, imidacloprid and metazachlor as active substances
o spremembi Direktive Sveta 91/414/EGS zaradi vključitve aklonifena, imidakloprida in metazaklora kot aktivnih snovi
That list includes aclonifen, imidacloprid and metazachlor.
Navedeni seznam vključuje aklonifen, imidakloprid in metazaklor.
For aclonifen and imidacloprid the rapporteur Member State was Germany and all relevant information was submitted on 11 September 2006 and on 13 June 2006 respectively.
Država članica poročevalka za aklonifen in imidakloprid je bila Nemčija, vse ustrezne informacije pa so bile predložene 11. septembra 2006 oziroma 13. junija 2006.
For metazachlor the rapporteur Member State was United Kingdom and all relevant information was submitted on 30 September 2005.
Država članica poročevalka za metazaklor je bila Združeno Kraljestvo, vse ustrezne informacije pa so bile predložene 30. septembra 2005.
The assessment reports have been peer reviewed by the Member States and the EFSA and presented to the Commission on 31 July 2008 for aclonifen, on 29 May 2008 for imidacloprid and on 14 April 2008 for metazachlor in the format of the EFSA Scientific Reports [4].
Poročila o oceni so medsebojno pregledali strokovnjaki držav članic in EFSA ter jih predstavili Komisiji v obliki znanstvenih poročil EFSA [4], in sicer 31. julija 2008 za aklonifen, 29. maja 2008 za imidakloprid ter 14. aprila 2008 za metaklozor.
These reports have been reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and finalised on 26 September 2008 in the format of the Commission review reports for aclonifen, imidacloprid and metazachlor.
Ta poročila so države članice in Komisija pregledale v okviru Stalnega odbora za prehranjevalno verigo in zdravje živali ter končno različico pripravile 26. septembra 2008 v obliki poročila Komisije o pregledu za aklonifen, imidakloprid in metazaklor.
It has appeared from the various examinations made that plant protection products containing aclonifen, imidacloprid and metazachlor may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review reports.
Različne preiskave so pokazale, da se za fitofarmacevtska sredstva, ki vsebujejo aklonifen, imidakloprid in metazaklor, lahko pričakuje, da na splošno izpolnjujejo zahteve iz člena 5(1)(a) in (b) Direktive 91/414/EGS, zlasti v zvezi z uporabami, ki so bile preučena in podrobno navedene v poročilu Komisije o pregledu.
It is therefore appropriate to include these active substances in Annex I, in order to ensure that in all Member States the authorisations of plant protection products containing these active substances can be granted in accordance with the provisions of that Directive.
Zato je primerno vključiti navedene aktivne snovi v Prilogo I, da se v vseh državah članicah v skladu z določbami navedene direktive lahko registrirajo fitofarmacevtska sredstva, ki vsebujejo te aktivne snovi.
Therefore, it is appropriate to require that aclonifen should be subjected to further testing for evaluation of residues in rotational crops and for the confirmation of the risk assessment for birds, mammals, aquatic organisms and non-target plants and that imidacloprid should be subjected to further testing for confirmation of the risk assessment for operators and workers and the risk to birds and mammals and such studies should be presented by the notifier.
Zato je primerno zahtevati, da se za aklonifen izvedejo dodatna testiranja za ovrednotenje ostankov posevkov v kolobarju in za potrditev ocene tveganja za ptice, sesalce, vodne organizme in neciljne rastline ter da se za imidakloprid izvedejo dodatna testiranja za potrditve ocene tveganja za izvajalce tretiranja in delavcev ter tveganja za ptice in sesalce, te študije pa mora predložiti prijavitelj.
Furthermore for metazachlor it is appropriate to obtain additional information on certain specific points.
Poleg tega je primerno zahtevati, da se za metazaklor pridobijo dodatne informacije o nekaterih posameznih točkah.
Article 5(5) of Directive 91/414/EEC provides that an inclusion may be reviewed at any time if there are indications that the criteria referred to in paragraphs 1 and 2 are no longer satisfied.
Člen 5(5) Direktive 91/414/EGS določa, da se vključitev lahko pregleda kadar koli, če obstajajo dokazi, da merila iz odstavkov 1 in 2 niso več izpolnjena.
The notifier has submitted information which at this stage is considered to be sufficient to address the relevance of certain metabolites.
Prijavitelj je predložil informacije, ki na tej stopnji zadostujejo za obravnavo ustreznosti nekaterih metabolitov.
However, a decision on the classification of metazachlor under Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances [5] is not yet finalised.
Vendar odločitev o razvrstitvi metazaklora v skladu z Direktivo 67/548/EGS z dne 27. junija 1967 o približevanju zakonov in drugih predpisov v zvezi z razvrščanjem, pakiranjem in označevanjem nevarnih snovi [5] še ni sprejeta.
Such decision might lead to the need for further information on these metabolites.
Takšna odločitev bi lahko pokazala potrebo po nadaljnjih informacijah o teh metabolitih.
The information submitted by the notifier to address the relevance of the metabolites 479M04, 479M08, 479M09, 479M11 and 479M12 with respect to cancer is, at this stage, considered as sufficient.
Informacije, ki jih prijavitelj na tej stopnji predloži za obravnavanje ustreznosti metabolitov 479M04, 479M08, 479M09, 479M11 in 479M12 v povezavi z rakom, so zadostne.
However, if a decision is adopted under Directive 67/548/EEC by which metazachlor is classified as ‘limited evidence of a cancerogenic effect’, further information will be needed on the relevance of those metabolites with respect to cancer.
Če je odločitev sprejeta v skladu z Direktivo Sveta 67/548/EGS, po kateri je metazaklor razvrščen pod „omejeni dokazi za rakotvorne učinke“, bodo potrebne nadaljnje informacije o ustreznosti navedenih metabolitov v povezavi z rakom.
Article 6(1) of Directive 91/414/EEC provides that the inclusion of a substance in Annex I to that Directive may be subject to conditions.
Člen 6(1) Direktive 91/414/ES določa, da za vključitev posamezne snovi v Prilogo I k navedeni direktivi lahko veljajo nekateri pogoji.
The inclusion of metazachlor should therefore be subject to a condition concerning the submission of further information in case that substance is classified under Directive 67/548/EEC.
Za vključitev metazaklora morajo zato veljati nekateri pogoji v zvezi s predložitvijo nadaljnjih informacij v primeru, da je navedena snov razvrščena v skladu z Direktivo 67/548/EGS.
Without prejudice to the obligations defined by Directive 91/414/EEC as a consequence of including an active substance in Annex I, Member States should be allowed a period of six months after inclusion to review existing authorisations of plant protection products containing aclonifen, imidacloprid and metazachlor to ensure that the requirements laid down by Directive 91/414/EEC, in particular in its Article 13 and the relevant conditions set out in Annex I, are satisfied. Member States should vary, replace or withdraw, as appropriate, existing authorisations, in accordance with the provisions of Directive 91/414/EEC.
Brez poseganja v obveznosti iz Direktive 91/414/EGS, ki izhajajo iz vključitve aktivne snovi v Prilogo I, je državam članicam treba omogočiti, da v šestih mesecih po vključitvi snovi pregledajo obstoječe registracije fitofarmacevtskih sredstev, ki vsebujejo aklonifen, imidakloprid in metazaklor, da zagotovijo izpolnjevanje zahtev iz Direktive 91/414/EGS, zlasti iz člena 13 in ustreznih pogojev iz Priloge I. Države članice v skladu z določbami Direktive 91/414/EGS obstoječe registracije po potrebi spremenijo, nadomestijo ali prekličejo.
Member States shall adopt and publish by 31 January 2010 at the latest the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 31. januarja 2010.
Member States shall in accordance with Directive 91/414/EEC, where necessary, amend or withdraw existing authorisations for plant protection products containing aclonifen, imidacloprid and metazachlor as active substances by 31 January 2010.
Države članice v skladu z Direktivo 91/414/EGS do 31. januarja 2010 po potrebi spremenijo ali prekličejo obstoječe registracije fitofarmacevtskih sredstev, ki vsebujejo aklonifen, imidakloprid in metazaklor kot aktivne snovi.
By that date they shall in particular verify that the conditions in Annex I to that Directive relating to aclonifen, imidacloprid and metazachlor are met, with the exception of those identified in part B of the entry concerning that active substance, and that the holder of the authorisation has, or has access to, a dossier satisfying the requirements of Annex II to that Directive in accordance with the conditions of Article 13 of that Directive.
Do navedenega datuma zlasti preverijo, ali so pogoji iz Priloge I k navedeni direktivi v zvezi s aklonifenom, imidaklopridom in metazaklorom, z izjemo tistih iz dela B besedila o navedeni aktivni snovi, izpolnjeni in ali ima imetnik registracije dokumentacijo ali dostop do dokumentacije, ki izpolnjuje zahteve iz Priloge II k navedeni direktivi v skladu s pogoji iz člena 13 navedene direktive.
By way of derogation from paragraph 1, for each authorised plant protection product containing aclonifen, imidacloprid and metazachlor as either the only active substance or as one of several active substances all of which were listed in Annex I to Directive 91/414/EEC by 31 July 2009 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles provided for in Annex VI to Directive 91/414/EEC, on the basis of a dossier satisfying the requirements of Annex III to that Directive and taking into account part B of the entry in Annex I to that Directive concerning aclonifen, imidacloprid and metazachlor respectively.
Z odstopanjem od odstavka 1 države članice znova ocenijo vsako registrirano fitofarmacevtsko sredstvo, ki vsebuje aklonifen, imidakloprid in metazaklor kot edino aktivno snov ali kot eno od aktivnih snovi, vključenih v Prilogo I k Direktivi 91/414/EGS najpozneje do 31. julija 2009, v skladu z enotnimi načeli iz Priloge VI k Direktivi 91/414/EGS na podlagi dokumentacije, ki izpolnjuje zahteve iz Priloge III k navedeni direktivi, in ob upoštevanju dela B besedila o aklonifenu, imidaklopridu in metazakloru iz Priloge I k navedeni direktivi.
in the case of a product containing aclonifen, imidacloprid and metazachlor as the only active substance, where necessary, amend or withdraw the authorisation by 31 January 2014 at the latest; or
če sredstvo vsebuje aklonifen, imidakloprid in metazaklor kot edino aktivno snov, najpozneje do 31. januarja 2014 po potrebi spremenijo ali prekličejo registracijo ali
in the case of a product containing aclonifen, imidacloprid and metazachlor as one of several active substances, where necessary, amend or withdraw the authorisation by 31 January 2014 or by the date fixed for such an amendment or withdrawal in the respective Directive or Directives which added the relevant substance or substances to Annex I to Directive 91/414/EEC, whichever is the latest.
če sredstvo vsebuje aklonifen, imidakloprid in metazaklor kot eno izmed več aktivnih snovi, registracijo po potrebi spremenijo ali prekličejo najpozneje do 31. januarja 2014 ali do datuma, določenega za takšno spremembo ali preklic v ustreznih direktivah, s katerimi so bile zadevne snovi dodane v Prilogo I k Direktivi 91/414/EGS, pri čemer se upošteva poznejši datum.
This Directive shall enter into force on 1 August 2009.
Ta direktiva začne veljati 1. avgusta 2009.